|
Post by otherottawaguy on Sept 14, 2016 12:34:23 GMT -5
Don't mean to be a Debbie-Downer here, but am wondering when we cross the 30 trading days closing below $1,00 threshold?
I was looking am counting 21days today, so am suspecting around the 28th of Sept unless something drastically changes.
Any speculation on what this might do to current share price, other than the obvious ways the FUDsters will spin it?
Does the company have six months from notification or from the dip below to a buck to rectify the situation?
OOG
|
|
|
Post by therealisaching on Sept 14, 2016 12:41:36 GMT -5
Don't mean to be a Debbie-Downer here, but am wondering when we cross the 30 trading days closing below $1,00 threshold?
I was looking am counting 21days today, so am suspecting around the 28th of Sept unless something drastically changes.
Any speculation on what this might do to current share price, other than the obvious ways the FUDsters will spin it?
Does the company have six months from notification or from the dip below to a buck to rectify the situation?
OOG Deficiency notice If a company is in violation of the continued listing standards for a period of 30 consecutive days, the NASDAQ sends a "deficiency notice." The most common reasons for a deficiency notice are a share price that falls below $1.00 or a market cap that falls below the stated minimum (as low as $5 million if other requirements are satisfied). Once a deficiency notice has been sent, the company has 90 days to comply with the continued listing standards, or 180 days if the violation was for a sub-$1.00 share price. In order to be compliant, the company's share price or market cap must rise above the minimum for at least 10 consecutive days in the 90-day (or 180-day) period.
|
|
|
Post by mannmade on Sept 14, 2016 13:59:33 GMT -5
So basically we have six months to get back above $1.00. Now that should be quite doable even with pending dilution. Scripts, scripts scripts...
|
|
|
Post by kbrion77 on Sept 14, 2016 14:02:49 GMT -5
So basically we have six months to get back above $1.00. Now that should be quite doable even with pending dilution. Scripts, scripts scripts... By January this thing is either $0 or $3.
|
|
|
Post by nylefty on Sept 14, 2016 14:06:34 GMT -5
So basically we have six months to get back above $1.00. Now that should be quite doable even with pending dilution. Scripts, scripts scripts... A company can ask for another 180 days and therefore would have a total of 360 days to get over $1. That was the case with Opexa Therapeutics (which is still in business): Opexa received a deficiency notice from NASDAQ in December 2014 and, following a 180-day cure period, received an additional 180 days from NASDAQ in June 2015 to regain compliance with the minimum bid price requirement.
www.streetinsider.com/Corporate+News/Opexa+Therapeutics+(OPXA)+Board+Approves+One-for-Eight+Reverse+Stock+Split/10923037.html
|
|
|
Post by seanismorris on Sept 14, 2016 14:26:59 GMT -5
This isn't a concern. Those Short may play it up, but MannKind will either succeed or fail before his becomes an issue.
Scripts and financial issues should dominate investor concerns. Near term, Scripts and Afrezza's Label interest me. If both look good by the end of the year, raising cash (dilution) and a reverse stock split become relevant.
I would have liked to see 2$ before years end, but unless Scripts explode I don't see that happening. Good results from the pediatric study would likely get us above 1$...
|
|
|
Post by mannmade on Sept 14, 2016 14:36:01 GMT -5
No need for a reverse split if we have all this time, imo. Unless they want to reduce number of shares outstanding.
I would think the Mann Foundation will have a say in how that is handled along with any financing moving forward.
|
|
|
Post by trondisc on Sept 14, 2016 16:06:00 GMT -5
No need for a reverse split if we have all this time, imo. Unless they want to reduce number of shares outstanding. I would think the Mann Foundation will have a say in how that is handled along with any financing moving forward. Gradual climb from scripts will prevent a reverse split. I am against a reverse split UNDER ANY circumstance. Long-term shareholders like me have already been screwed enough. Get this POS back to $5 then we can talk dilution.
|
|
|
Post by mnkdfann on Sept 14, 2016 16:11:30 GMT -5
Even if delisted from Nasdaq, it can still be listed and trade OTC. Many stocks do that.
In any case, MNKD is still listed and trades on the Tel Aviv index, does it not?
|
|
|
Post by gamblerjag on Sept 14, 2016 16:30:23 GMT -5
As someone indicated and this has been discussed before the last time we were at this level.. Bottom line.. MNKD with NASDAQ extensions which is always or almost always granted has 1 year to be in compliance to maintain s/p for 1.00 for over 10 days. So lets forget the 6 months since that would not be the final timeline. Also, as someone else said that with everything that is in the works, even if all doesn't come to fruition, this stock will be much higher than 1.00 in the next year... if for some reason it's not... it would be because the Company would probably not be around.
|
|
|
Post by gamblerjag on Sept 14, 2016 16:34:37 GMT -5
exactly Mannmade.
|
|
|
Post by seanismorris on Sept 14, 2016 17:27:32 GMT -5
I agree no reverse split now, but even with success this year and into the next, I expect significant dilution. 50% dilution is possible, even likely.
Afrezza (MannKind) won't be profitable next year even with the most optimistic estimates, the trials for the TS prospects are going to be expensive starting next year. Add that to operations expenses, I could see the need to raise 200m. The other option is partnerships for the TS, but if things are going well dilution is better than taking a big cut to future profits.
A global Afrezza's partnership makes sense, but management is probably leary of getting involved in another one in the US. Sanofi almost killed the company, and now that MannKind has a sales team inhouse... I'd consider a US partnership a desperation cash raising move.
We really need MNKD above 5$ by the end of next year, so a split remains on the table. We need to reduce the share count in the worst way.
Re: the Mann Foundation I have no idea what they are doing... A hands off approach is my best guess. They may wish to reduce their exposure in MannKind. The other option is going all in, and I haven't gotten that signal.
If I was the foundation I would have taken over the board...
|
|
|
Post by mannmade on Sept 14, 2016 18:10:39 GMT -5
So with all the doom and gloom... And yes I agree, until resolved, money is a big issue as are scripts... But I do think they will get resolved.... and we will see progress on both by the end of the year. However, even with some dilution, again imo, the MannKind story is picking up a little bit of steam, slowly but surely... Let's review... 1. AFREZZA 2.0 well underway and we should see steady climb of scripts moving forward... 2. Epi is a potential big opportunity that they seem to have had a jump on. 3. RSL is out there with a milestone payment of some kind by end of year for an as yet unknown product partnership. 4. Mintaka seems to have a partnership with Mnkd for inhaled oxytocin. 5. Not to mention their pipeline (and I won't for purposes of this post as the products in the pipeline are further out from production) So to me it looks like they have four very real products/partnerships (an actual portfolio of drugs...) that could all be available next year. While AFREZZA may be the only one with blockbuster potential, the others will contribute to revenue and the image/press of MannKind and then be reflected in the share price imho... The sum of all parts... It is the beginning of the inhaled revolution... Clinton was ahead of his time... Only now he can inhale...
|
|
|
Post by dejude42 on Sept 14, 2016 18:15:51 GMT -5
|
|
|
Post by dejude42 on Sept 14, 2016 20:59:54 GMT -5
I wish to share something, I sent to several government agencies last week. The concept was given to me in a lecture from a Lawyer at an Ohio Adult Guardianship (OGA) conference. He spoke on Creativity Manipulation (CM) begins without statistics, because no numbers are available. His belief, "CM is always due to lack of Monitoring." He continued, "Where there is no monitoring provided, devastating results will become a reality." With these thoughts, this is what I delivered to SEC, FBI and the White House tip, complaint and suggest lines. Any feed back positive or negative would be appreciated.
The current NASDAQ stock market (using the MNKD stock) shows signs of a constructively manipulated market. The ease of share price reduction through relinquishment of shares produces minimum cost. Then the continuous buy back of reduced price of shares give profit to start the process over. The driven lower ASK PPS created by these share owners desire is not a fair market. Long share owners and stock funded corporations are to be protected by SEC protocol and mission statement. If not investors are being misled by a pyramid scheme. The failure to monitor trade actions can be devastating. Stock Long holders support stock funded corporations, and success or failure is being created by the lack of statistics. Trade action without the numbers allows share relinquishment failure to be created and not to monitor is devastating the stock supporters. Every Major operation has monitors. Monitored systems are proven to be successful. Monitored systems gather statistics and the numbers targeted in the operations remove doubts or will show a discrepancy. Monitored systems allow the controller to act quickly and efficiently; providing the tools needed to enforce and fine the rule breakers. A Constructively Manipulated stock market allows the relinquishment of shares in trade actions to form price: which gives advantage toward shorting or lowering current ASK PPS (price per share). The direct lowering comes from Bid and ASK Spread Gaps or Windows into which a Bid (buy) or ASK (sell) order maybe placed. The important key is to understand: BID and ASK need RELINQUISHMENT of shares. These shares are needed to fill each respectfully BID or ASK current page PPS level. At the instant when either the current top BID or ASK page PPS LEVEL has ZERO: the shares in BID (BID page lowers) or the shares in ASK (ASK PAGE RISES) this creates a widen spread. This newly created widen spread allows any new BID or ASK order resulting in a new Current PPS BID and ASK top page. These inserted trades in a widen Spread result in these actions: Bid orders Tighten spread (seldom seen) and Ask orders lower current ASK PPS (constructively manipulated). Very little cost is experienced to those wishing to lower. Owner Relinquishment of shares is the tool to BID create movement with stair step downward shallow page level filling. Gap ASK orders stair step ASK PPS down quickly at no cost to place order while stacking shares block ASK PPS rise. The cost becomes very high toward the stock share supporter who must come up with monies to buyout new lower page levels. It is hard to create statistics without the numbers, and failure to monitor can be devastating. God have mercy on the long term investor and stock supported corporation, I know the trades actions I explained can be created, please try these trade methods. Actions prove the fact that stocks can be constructively manipulated, very difficult to make statistics without numbers, and failure to monitor can be devastating to our freedom as American investors. Patterns bring life to the intentions of the doer.
|
|